Objectives:
To assess the clinical implication of chromosomal microarray analysis (CMA) in prenatal diagnosis of Congenital Anomalies of the Kidney and the Urinary Tract (CAKUT). Methods: We reviewed 107 cases of CAKUT detected by prenatal ultrasound in our Fetal Nephrourological Unit from 2015 to 2016. CAKUT cases were classified into 3 groups: 79 collecting system anomalies (including hydronephrosis, duplex collector system, megacystis and LUTO); 14 renal dysplasias (including echogenic, hypoplastic, polycystic and mulitcystic kidneys), and 14 number, fusion or location anomalies. Invasive test (amniocentesis or CVS) for CMA were always offered with the exception of isolated mild pelvic dilatation. CMA was performed by qGenomics (qChipCM, 8x60K). Results: From 33 (31%) genetic studies performed, 5 (15%) anomalies were found: 3 of them in dysplastic and echogenic kidneys with normal amniotic fluid (two microdeletions 17q12 and one 47,XXY) and 2 in collecting system anomalies (T21 in a first trimester megacystis and untypical microdeletion 22q11.21 in one case of bilateral pelvic dilatation + ventricular septal defect, undetected by conventional karyotype). Of this 5 chromosomal anomalies, there was one termination of pregnancy (T21). The 3 newborns with echogenic kidneys had been strictly followed in Nephro-Pediatrics, Genetics and Neurological Units presenting preserved renal function until now, but persistent anomalous appearance of kidneys in ultrasound. The newborn with untypical 22q11.21 microdeletion presents a severe neurological delay and normal renal function. Conclusions: Chromosomal microarray analysis could help in the diagnosis and prenatal counselling of CAKUT, particularly in those cases that represent a diagnostic dilemma such as echogenic/dysplastic kidneys with normal amniotic fluid.
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In utero therapy for fetal heart block: UCLH, London experience A. Yulia, D. Wiliams, P. Pandya
Fetal Medicine, EGA Institute for Women's Health, UCL and UCLH NHS Foundation Trust, London, United Kingdom
Objectives: Congenital complete atrioventricular (AV) block is defined as the dissociation of atrial and ventricular contractions which causes a significant drop in the ventricular rate and it may cause fetal cardiac failure, including fetal hydrops and intrauterine demise. The optimal prenatal therapy for affected fetuses has proven controversial. It can be associated with underlying structural heart disease or can develop in association with a multifactorial, autoimmune process, associated with the trans-placental transfer of maternal autoantibodies to Ro and La proteins, which affect the fetal cardiac conduction system. We administered intravenous immunoglobulin (IVIG) and/or dexamethasone to the mothers of nine fetuses with heart block caused by maternal antibodies. The aims is to review the prenatal treatment of AV. Methods: Over the past 5 years, we diagnosed 11 cases of fetal heart block at UCLH at 20+3 to 28+4 weeks and treated mothers with dexamethasone 4 mg orally each day for 2 weeks and 2mg each day afterwards for the remainder of the pregnancy and/or intravenous IVIG for 5 days and then 2 weekly until delivery. Results: They were 31 women with 40 pregnancies who were positive with anti-Ro and/or anti-La. 29 pregnancies were not affected by heart block. 11 pregnancies were affected by complete heart block, 2 pregnancies were not treated. In the remaining 9 pregnancies, 3 pregnancies were treated with dexamethasone, 5 pregnancies were treated with IVIG, 1 treated with both. 3 pregnancies which was treated with IVIG, has reduction in the degree if hear block and resolution for the effusions and ascites in the other two cases. Those who were treated with IVIG or dexamethasone did not show any further progression of the heart block. Conclusions: IVIG may be a new effective approach to treat and prevent CHB in fetuses with positive maternal circulating antibodies through a potential reduction of maternal autoantibody titres as well as fetal inflammatory responses.
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Prenatal detection of congenital heart defects by sonographers on routine ultrasound examination in second trimester of pregnancy
Obstetrics and Gynecology, Lund University, Malmö, Sweden
Objectives: Prenatal detection of congenital heart disease (CHD) affects the perinatal management and reduces morbidity and mortality of children. The aim of the study was to assess the prenatal detection rate of CHDs requiring invasive surgical intervention within the 1st year of life at routine ultrasound examination of the fetus in the second trimester in Malmö, Sweden. Methods: This is a retrospective observational study. All infants with a CHD that required surgical or catheter based intervention in the first year of life and born between 2006.06.30 -2012.06.30 were included into study. During that period 32628 newborns were born in families residing in Malmö. Fetuses with 2nd trimester termination because of prenatally detected CHDs were also included. Timing of the diagnosis was determined through information in Swedish national databases of heart diseases and operations, local registries and patient records. Results: We identified 82 children residing in Malmö and born with CHD requiring surgical or catheter based intervention in the first year of life. 49 of 82 (60%) cardiac defects went undetected. 36/49 (73%) CHDs were detected on the 2nd trimester routine scan. 23 of the 36 (64%) chose termination of pregnancy. Isolated septal defects were prenatally detected only in 6 of 30 (20%) cases. Among the 52 children with an isolated cardiac defects (i.e. no other congenital malformations) 29/52 (56%) were prenatally detected. Among 14 fetuses affected by multiple organ malformations 11 (79%) CHDs were prenatally detected. Conclusions: In conclusion our study showed that 60% of clinically significant CHDs were detected by second trimester ultrasound examinations in Malmö ultrasound unit. This result is higher than that presented in previous published studies, however regarded as not sufficient. Isolated septal defects were most often missed at the ultrasound examination. Continuous education and training of sonographers and standardised and continuous quality control are required improve the results.
